Package 70625-207-01

{"route": ["ORAL"], "spl_id": "49fc4d28-ef67-e6ac-e063-6394a90a0020", "openfda": {"nui": ["N0000175427", "N0000190114", "N0000185503", "N0000182137", "N0000187061"], "unii": ["A6IEZ5M406"], "rxcui": ["616749", "728231"], "spl_set_id": ["f3c09979-a44a-4197-97d2-29a207b6fc73"], "pharm_class_epc": ["Anti-anginal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "manufacturer_name": ["SunGen Pharma LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70625-207-01)", "package_ndc": "70625-207-01", "marketing_start_date": "20200401"}, {"sample": false, "description": "500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70625-207-02)", "package_ndc": "70625-207-02", "marketing_start_date": "20200401"}], "brand_name": "Ranolazine", "product_id": "70625-207_49fc4d28-ef67-e6ac-e063-6394a90a0020", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Anti-anginal [EPC]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "70625-207", "generic_name": "RANOLAZINE", "labeler_name": "SunGen Pharma LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ranolazine", "active_ingredients": [{"name": "RANOLAZINE", "strength": "1000 mg/1"}], "application_number": "ANDA212781", "marketing_category": "ANDA", "marketing_start_date": "20200401", "listing_expiration_date": "20271231"}